Key result
Mini-AVR via right minithoracotomy with central cannulation demonstrates excellent safety with ~1% early mortality.
Why the study?
Minimally invasive aortic valve replacement with sutureless bioprosthesis via right minithoracotomy with central cannulation may improve clinical outcomes, especially in high-risk and elderly patients, but safety and perioperative outcomes require evaluation.
Population
203 patients undergoing isolated AVR for aortic valve disease
Comparison
Mini-AVR with sutureless bioprosthesis via right minithoracotomy with central cannulation (no comparator)
Design
Single-center retrospective cohort study
Follow-up
4 months
Authors
Loading...
Supports feasibility of this approach in older patients; hypothesis-generating pending randomized comparisons.
Cohort (n=203)
No
Minimally invasive aortic valve replacement with a sutureless bioprosthesis via right minithoracotomy and central cannulation demonstrates excellent early safety and low mortality (1%) in an older patient cohort.
Sef et al. (2020) conducted a cohort in Aortic valve disease (n=203). Minimally invasive aortic valve replacement via right minithoracotomy with central cannulation was evaluated on 30-day and 4-month mortality. Minimally invasive aortic valve replacement via right minithoracotomy with central cannulation demonstrated excellent early safety, with a 1% mortality rate at 30 days and 4 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: